The 340B drug discount program becomes more essential by the minute as safety-net hospitals face steep shortfalls in federal assistance under the Affordable Care Act. The Wall Street Journal reports today (subscription required) about how many of New York City's "financially strapped" 340B hospitals "are scrambling to sign up people for health coverage through New York state's … [Read more...]
TogetherRx Access Closes Doors on 2M customers
TogetherRx Access, a drug discount card program sponsored by drug companies, is being discontinued as of Feb. 28, 2014. The reason? Big Pharma says participants will get a better deal on prescriptions by getting insured through the Affordable Care Act or Medicaid. “We have determined that individuals and families who need help obtaining their prescription medicines may be … [Read more...]
Congress Passes Compounding Pharmacy Oversight Bill
Utilization soared during recent drug shortagesNovember 20, 2013— The U.S. Senate has passed legislation clarifying Food and Drug Administration (FDA) oversight of compounding pharmacies, clearing it for President Obama's signature. The House passed the bill in July. … [Read more...]
340B Recertification Postponed for STD and TB Clinics and Ryan White Grantees
Annual affirmation of eligibility now scheduled for first quarter 2014November 19, 2013—The Office of Pharmacy Affairs (OPA) has delayed the start of 340B recertification for sexually transmitted disease (STD) clinics, tuberculosis (TB) clinics, and Ryan White HIV/AIDS program grantees until the first quarter of 2014. Recertification was scheduled to begin for them yesterday. … [Read more...]
Big Pharma Profiteering on Orphan Drugs (Part 3)
The Seattle Times has published the next installment of its investigation of drug industry profiteering from orphan drugs. It's entitled How a Drug for a Few Patients Was Turned Into $81 Million in Sales. The story describes how Cell Therapeutics Inc. systematically spread the word among physicians (sometimes with the assistance of patient advocacy groups) about potential … [Read more...]
Drug Companies Disbanding Together Rx Access Discount Program
Cardholders "may be better served" by insurance exchanges, Medicaid, and other PAPs, they sayNovember 18, 2013—Eight leading drug manufacturers are pulling the plug on a discount card program used by more than 2 million people who are ineligible for Medicare and have no prescription drug coverage. … [Read more...]
Groups Say Trade Pact Threatens 340B
Letter to Obama warns of limits on prescription drug cost-control mechanismsNovember 15, 2013—Drug-pricing provisions reportedly being advanced by U.S. negotiators for a proposed multilateral trade treaty could subject 340B drug discounts "to challenge by manufacturers," a coalition of health, consumer, labor, and retiree groups says in a recent letter to President Obama. … [Read more...]